Trial Profile
Safety and Efficacy of Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 11 Nov 2020
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Pazopanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 03 Nov 2020 Status changed from not yet recruiting to recruiting.
- 17 Sep 2018 Status changed to not yet recruiting.
- 20 Aug 2018 New trial record